e-Therapeutics plc announced that following its full year results statement on 22 March 2016 which highlighted the Company's strategic refocus on its discovery platform, Steve Self will stand down as Development Director and leave the Company on 30 September 2016. Steve joined e-Therapeutics in December 2010 following a distinguished career at The Wellcome Foundation, Boots Healthcare and as R&D Director of Merck's Generic Global business.